[Federal Register Volume 88, Number 86 (Thursday, May 4, 2023)]
[Notices]
[Page 28570]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-09452]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Proposed 
Reorganization

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Heart, Lung, and Blood Institute (NHLBI) of the 
National Institutes of Health (NIH) will host a public hearing to 
enable discussion of the Institute's proposal to reorganize the 
Division of Lung Disease (DLD). The proposed reorganization aims to 
ensure effective oversight, alignment of expertise, and translation of 
knowledge within and across research areas in the lung disease field. 
It establishes a new branch structure that will strategically position 
leadership over DLD programs, balance workload, and enhance depth/
succession planning for ingrained operational sustainability. There 
will be no impact on the National Center on Sleep Disorders Research as 
a result of the restructuring. The online forums will allow members of 
the public to review the reorganization proposals and submit comments.

DATES: The first public hearing will take place June 6, 2023, at 
approximately 11:30 a.m. E.T. during the open session of the National 
Heart, Lung, and Blood Institute Advisory Committee meeting. The second 
public hearing will take place on June 7, 2023, from 12:00 p.m. to 1:00 
p.m. E.T. using the NHLBI DLD Director's Twitter account. Any 
interested person may also file written comments by sending an email to 
[email protected] prior to June 7, 2023. The statement should 
include the individual's name, and when applicable, professional 
affiliation.

ADDRESSES: The following email address may be used for comments on the 
reorganization: [email protected].
    The link to the videocast for the first public hearing to occur 
during the open session of the NHLBI Advisory Council meeting will be 
posted online at: https://www.nhlbi.nih.gov/about/advisory-and-peer-review-committees/advisory-council.
    The second public hearing will be held via Twitter using 
@NHLBI_LUNGDir.

FOR FURTHER INFORMATION CONTACT: Tony Jackson, Chief of Staff, Division 
of Lung Disease, National Heart, Lung, and Blood Institute, National 
Institutes of Health, Rockledge Center I, 6705 Rockledge Drive, 4th 
Floor, Bethesda 20817, 301-435-0233, [email protected].

SUPPLEMENTARY INFORMATION: The NIH Reform Act of 2006 (42 U.S.C. 
281(d)(4)) requires public notice of proposed reorganization plans. 
This announcement and the public forum serve as that notice.

    Dated: April 27, 2023.
James F. Gude,
Acting Executive Officer, National Heart, Lung and Blood Institute, 
National Institutes of Health.
[FR Doc. 2023-09452 Filed 5-3-23; 8:45 am]
BILLING CODE 4140-01-P